Quality Control in the age of Risk Management, An Issue of Clinics in Laboratory Medicine

— —

James O. Westgard, Ph.D., FACB (Private Practice) Sten Westgard, MS (Private Practice)

Quality Control in the age of Risk Management, An Issue of Clinics in Laboratory Medicine

James O. Westgard, Ph.D., FACB (Private Practice), Sten Westgard, MS (Private Practice)

$163.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Elsevier - Health Sciences Division
28 January 2013

Medicine; Clinical & internal medicine; Haematology; Pathology

Series: The Clinics: Internal Medicine

Summary
Details

"In October of 2011, CLSI published a new guideline EP23A on ""Laboratory Quality Control Based on Risk Management. In March, 2012, CMS announced its intention to incorporate key concepts from EP23A into its Interpretative Guidelines and QC policy for ""Individualized Quality Control Plans. Thus begins a new era of Quality Control in the Age of Risk Management. This issue is intended to help laboratories with the transition between traditional QC practices and the new risk management approach. Laboratories face a steep learning curve to apply risk analysis for identifying and prioritizing failure-modes, developing and implementing control mechanisms to detect those failure-modes, and assessing the acceptability of the residual risks that exist after implementation of a QC Plan. One of the main benefits of the new risk analysis based QC Plans should be an integration of all the control mechanisms that are needed to monitor the total testing process, including pre-analytic, analytic, and post-analytic controls.

One of the main risks of the new approach is an expectation that Statistical QC is no longer important, even though SQC still remains the most useful and flexible approach for monitoring the quality of the analytic process. The key to the future is the successful integration of all these control mechanisms to provide a cost-effective quality system that monitors all phases of the total testing process. This issue should help laboratories understand the evolution of QC practices to include risk management, but also to recognize the need to maintain traditional techniques such as Statistical QC, especially during the transition to well-designed and carefully-validated QC Plans. Risk analysis may be risky business unless laboratories proceed carefully and cautiously."

Edited by: James O. Westgard Ph.D. FACB (Private Practice), Sten Westgard, MS (Private Practice)
Imprint: Elsevier - Health Sciences Division
Country of Publication: United States
Volume: 33-1
Weight: 460g
ISBN: 9781455771103
ISBN 10: 1455771104
Series: The Clinics: Internal Medicine
Pages: 217
Publication Date: 28 January 2013
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active